Quote:

---

I tis interesting that they are not just looking at colon cancer, but relapsed or refectory colon cancer. This means to me that if Leronlimab shows positive results, it is not just another treatment but a treatment that works when all other fail.

---

Because the existing drugs do not work very well it's much easier to prove efficacy. Then you can take the money made from that sub- indication and roll it into a larger general population trial.